UK +44 (0)1865 849841
Malaysia +60 3 2117 5193
  • Bridging The Policy-Practice Divide In Genome-Editing For Agriculture

    Regulation of emerging technology such as genome editing has mainly focused on responding to the consequences of innovation.

  • Four challenges in developing AI algorithms for medical imaging

    With so much emerging on the scene and the inherent technical challenges involved in extracting data from images, what we really want to be focusing on is this question: how robust and reliable is the application itself?

  • The top 4 challenges for microbiome companies – NIZO

    Microbiome research is abundant and profoundly inspiring. But despite the promise, companies in the field face challenges.

  • How do we build the solutions that will transform healthcare’s future?

    We are building the solutions that will revolutionise healthcare in the future: solutions that will transform the trust relationship between the industry and patients.

The Plant Genomics and Gene Editing Congress Presentation Slides

Following the Plant Genomics and Gene Editing Congress: Europe, we have made the following presentation slides from Ana Atanassova, Ian Bancroft, Nigel Halford and Kim Hammond-Kossack available.

Read More

Increasing plant protein digestion in an in vitro model

Population increases and patterns of consumption will put pressure on animal protein supply and price over the coming decades. Plant proteins are a viable alternative, but have a lower digestibility then animal proteins.

Read More

The Liquid Biopsy Workflow

Anders Stahlberg works both in the academic setting as Associate Professor at the University of Gothenburg and in the clinical setting at Clinical Genetics & Genomics, Sahlgrenska University Hospital. Together with his colleagues, this means all aspects of circulating cell-free tumour DNA are covered; from basic science and development, understanding why and how liquid biopsies should be undertaken, to clinically focused questions that the patient will hopefully benefit from.

Ahead of the Liquid Biopsies Congress later this year, we spoke to him about his work.

Read More

Microbiome R&D & Business Collaboration Forum presentation slides

Following the Microbiome R&D & Business Collaboration Forum, we have made the following presentation slides from Karoline Faust, Dirk Hadrich, Lesley Hoyles & Jos Seegers available.

Read More

The benefits of lysates vs live probiotic cultures in skincare

Numerous skincare brands incorporate lysates in their formulas. However, few brands are able to harness live and active bacteria in addition to the lysates. Neither is an easy task when it comes to formulation however, we can all acknowledge and appreciate the difficulty in working with live probiotics. So, what are the benefits and is this extra challenge worth the effort?

Read More

Enhancing Photosynthesis: a Big Deal

The PhotoSeed Technology

Enhancing photosynthesis is a critical step to increasing crop yields. This complex 156 step biochemical process has been the subject of many studies in multiple crops. While some step wise gains have been made, the true potential for increasing photosynthesis has not been realized potentially due to the negative feedback mechanisms that exist within plants to regulate this process.

Read More

Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress Slides

Following the Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress, we have made the following presentation slides from Jonathan Cartoux, Denis Decubber, Hani El-Sabbahy, Julia LeachCorne Stroop.

Read More

FMT-based discovery: from platform to product

Fecal microbiota transplant (FMT) is probably the microbiome based therapy that has received the most media attention. It seems journalists love to talk about poo.

This has given momentum to research in the field. As the amount of trial data and fear of antibiotic resistance grows, FMT is now a much more common treatment for conditions like clostridioides difficile infection (CDI).

Read More

Increasing plant protein digestion in an in vitro model

Population increases and patterns of consumption will put pressure on animal protein supply and price over the coming decades. Plant proteins are a viable alternative, but have a lower digestibility then animal proteins.

Read More

The Liquid Biopsy Workflow

Anders Stahlberg works both in the academic setting as Associate Professor at the University of Gothenburg and in the clinical setting at Clinical Genetics & Genomics, Sahlgrenska University Hospital. Together with his colleagues, this means all aspects of circulating cell-free tumour DNA are covered; from basic science and development, understanding why and how liquid biopsies should be undertaken, to clinically focused questions that the patient will hopefully benefit from.

Ahead of the Liquid Biopsies Congress later this year, we spoke to him about his work.

Read More

Microbiome R&D & Business Collaboration Forum presentation slides

Following the Microbiome R&D & Business Collaboration Forum, we have made the following presentation slides from Karoline Faust, Dirk Hadrich, Lesley Hoyles & Jos Seegers available.

Read More

The benefits of lysates vs live probiotic cultures in skincare

Numerous skincare brands incorporate lysates in their formulas. However, few brands are able to harness live and active bacteria in addition to the lysates. Neither is an easy task when it comes to formulation however, we can all acknowledge and appreciate the difficulty in working with live probiotics. So, what are the benefits and is this extra challenge worth the effort?

Read More

Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress Slides

Following the Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress, we have made the following presentation slides from Jonathan Cartoux, Denis Decubber, Hani El-Sabbahy, Julia LeachCorne Stroop.

Read More

FMT-based discovery: from platform to product

Fecal microbiota transplant (FMT) is probably the microbiome based therapy that has received the most media attention. It seems journalists love to talk about poo.

This has given momentum to research in the field. As the amount of trial data and fear of antibiotic resistance grows, FMT is now a much more common treatment for conditions like clostridioides difficile infection (CDI).

Read More

Probiotics Congress: Europe Presentation Slides

Following the Probiotics Congress: Europe, we have made the following presentation slides from Jean-Francois Brugère, Grégory Lambert, Bruno Pot and Koen Venema available.

Read More

The Skin Microbiome & Cosmeceuticals Congress presentation slides

Following the Skin Microbiome & Cosmeceuticals Congress: Europe, we have made the following presentation slides from Richard Andrews, Ingmar Claes, Marie Drago & Maya Ivanjesku available.

Read More

The Plant Genomics and Gene Editing Congress Presentation Slides

Following the Plant Genomics and Gene Editing Congress: Europe, we have made the following presentation slides from Ana Atanassova, Ian Bancroft, Nigel Halford and Kim Hammond-Kossack available.

Read More

Enhancing Photosynthesis: a Big Deal

The PhotoSeed Technology

Enhancing photosynthesis is a critical step to increasing crop yields. This complex 156 step biochemical process has been the subject of many studies in multiple crops. While some step wise gains have been made, the true potential for increasing photosynthesis has not been realized potentially due to the negative feedback mechanisms that exist within plants to regulate this process.

Read More

Positive Regulatory Developments for the U.S. Ag Tech Industry

2019 may prove to be propitious in terms of meaningful improvements to the regulatory strictures facing agricultural biotech and biologically based products.

In a move that will hopefully lead to positive changes in the regulatory situation facing ag biotech products, on June 11, 2019, President Trump signed an Executive Order directing the heads of the U.S. Department of Agriculture (USDA), Environmental Protection Agency (EPA), and Food and Drug Administration (FDA) to take specific steps to streamline and improve the regulatory processes applicable to the products of agricultural biotechnology.

Read More

A global perspective on the developments in biotech regulations

The ECJ ruling on GMOs has raised pertinent issues. How will it impact on current and future research? What are the optimum routes to progressing plant research?

In light of the ruling, it was a good time to welcome experts in policy and regulatory affairs to the recent 7th Plant Genomics & Gene Editing Congress: Europe to explore these issues. We’re lucky to be able to share this presentation from the event for those that weren’t able to make it. Watch it here.

Read More

Assessment of the European Court of Justice ruling on gene editing for crop improvement

Anyone involved in the field of agriculture and biotechnology would have been unable to ignore the ECJ ruling on case C-528/16 in July 2018. The ruling confirmed that all plants obtained by any form of mutagenesis are GMOs as defined by Directive (EC) no. 2001/18 and rejected an annulment of mutagenesis exemption (Annex IB of Directive 2001/18. With significant ramifications across the industry, the ECJ stance on gene edited crops and GMOs was a major focus of the 7th Plant Genomics & Gene Editing Congress: Europe.

Read More

A novel fungal endophyte confers fitness benefits to crops

Researchers at the Polytechnic University of Madrid (UPM) in Spain, in collaboration with scientists with PlantResponse Biotech, S.L., are conducting research on a novel fungal endophyte that confers crop fitness benefits, particularly in alkaline soils.

Read More

Using pathogen genome-informed strategies to understand the molecular mechanism plant disease

A key feature of our Congresses is the opportunity given to early career researchers to present their work.

At the upcoming 7th Plant Genomics & Gene Editing Congress: EuropeEgem Ozbudak will be one of four early career researchers to be given a 15-minute platform to present their work and receive a free registration pass for both days of the conference.

He will be discussing his research project on Colletotrichum acutatum, the causative agent of anthracnose crown and fruit rot, recognized as the second most important pathogen of strawberries on the globe due to its economic impacts.

Read More

Developing Live Microbial Products with Science Driven Understanding

Günter Welz is part of the Open Innovation and Strategic Partnerships department at Bayer. He scouts for and builds relationships with external innovators in academia and business to enrich Bayer’s R&D pipeline, using various tools like the Open Innovation website and the venture capital arm.

Read More

Examining Blockchain Systems & Designing Smart Contracts

The blockchain has the potential to enable the collaboration between patients, researchers, and care providers to provide individualised care for patients, but how can this technology be harnessed in a practical way?

This was one of the key questions that was asked at the Blockchain in Healthcare Congress and we had the pleasure of welcoming an array of expert speakers from pharma, academia, and industry to provide the answer.

Read More

The role of extrinsic motivation in sports and physical activity

Motivation is one of the most significant psychological concepts in many areas of life – from work and education to achieving personal goals. In sports and physical activity, motivation plays an especially important part due to the fact that, to millions of people worldwide, staying fit and active is not an obligation or a professional prerequisite, but rather a personal goal. Blockchain technology, together with elements of gamification, may actually help people achieve this goal.

Read More

Conciliating Blockchain and GDPR

Aurélie Bayle is a Data Protection Officer at be-ys: a role she considers to be at the heart of the new legal framework for any company.

Before GDPR came into effect on 25th May 2018, she was working towards global compliance, which involved completing all the steps given by the Article 29 Data Protection Working Party, an advisory board made up of a representative from the data authority of each EU Member State, the European Data Protection Supervisor, and the European Commission. Her duties have included auditing the structures and processes, preparing the data protection impact assessments, checking the compliance of processing activities, analysing the risks of the processing in the medical area, preparing new processes and policies about data protection, and asking data processors about their own compliance.

Read More

When Blockchain Meets the Right to be Forgotten: Technology Versus Law

Over the past few years, the popularity of the blockchain and cryptocurrencies has increased and has reached important notoriety, not only in scientific and IT journals, but also in the media. Although there are many kinds of cryptocurrencies in circulation nowadays, the most popular is Bitcoin.

Read More

Supporting Blockchain Startups: An Open Letter from Katherine Merton

Dear colleagues,

The blockchain technology market is expected to grow to 2.3 billion US dollars by 2021, from 339.5 million US dollars in 2017. [1] With an annual growth rate of 61.5%, it is one of the fastest growing technologies in the healthcare industry.

Read More

The Big List of Microfluidics Companies & Investors

The microfluidic-based devices market has been growing since 2014 due to the increasing point of care testing demand and the miniaturisation of microfluidic chips. 

Read More

What will we do with all this data?

The amount of data we are creating every day has increased exponentially to match the rise in use of smart and connected devices. The internet of things has connected every aspect of our lives to the digital realm: most of these devices operate by tracking your habits, movements, preferences, voice, and more, then logging those habits online. Specifically, the collection of health data has become abundant, because most people now have or wear some sort of device to track daily patterns, steps, cycles, and more. Even our phones often default to track these things for us, whether we choose to enable the function or not.

Read More

How Standards & Standardised Infrastructure Fuel Innovation

It might surprise a lot of people to learn that standards can be viewed as a tool to support innovation, to set businesses free and to focus on the core of their product where their expertise lie. When working with the use of electronic communication systems within the entire healthcare sector, the main focal point is often ensuring a good support for collaboration and work processes.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive